Uncovering the facts, Holding government accountable.
Published: September 4, 2019
FOIA to FDA Seeking Email Communications with the White House Regarding the Anti-Depressant Nasal Spray Spravato
FOIA request to the U.S. Food & Drug Administration seeking email communications between FDA officials and the White House regarding the anti-depressant nasal spray Spravato (esketamine). HHS-FDA-19-1105
Select a tag below to see a full list of related documents